1. The Regulatory Landscape and Compliance Imperatives Operating an Enterprise Resource Planning (ERP) platform within a GxP-regulated life sciences organization carries exceptionally high stakes, as any error in a batch record or quality process can directly compromise patient safety and Read More …
Tag: QA
A Comprehensive Analysis of ICH Q9(R1) and the Evolving Standards of Quality Risk Management
The formal adoption of the ICH Q9(R1) guideline in January 2023 represents a pivotal advancement in the global harmonization of pharmaceutical quality standards, addressing nearly two decades of implementation experience and evolving industrial complexities. Originally introduced in 2005, the ICH Read More …
The Strategic Transition to Quality 4.0: Integrating Digital Intelligence into Organizational Excellence
The global industrial landscape is presently navigating a foundational transformation, shifting from traditional quality management paradigms to a digitized, interconnected framework known as Quality 4.0. This evolution represents the alignment of quality management practices with the technological advancements of the Read More …
The Definitive Guide to CAPA Management: Remediating Ineffective Systems and Preventing Repeat Deviations
Executive Summary In the global pharmaceutical landscape of 2026, the Corrective and Preventive Action (CAPA) system is no longer viewed as a mere documentation exercise. It is the engine of continuous improvement. This guide explores why the WHO often cites Read More …
Modern Laboratory Data Integrity: LIMS, ALCOA+, and Preventing “Testing into Compliance”
The contemporary industrial landscape, particularly within the pharmaceutical and high-precision textile sectors, is currently undergoing a radical transformation driven by the convergence of stringent regulatory oversight and the urgent necessity for sustainable technological innovation. At the heart of this evolution Read More …
Explore the most common pharmaceutical deviations in Bangladesh
Explore the most common pharmaceutical deviations in Bangladesh: Learn expert Root Cause Analysis (RCA) techniques and CAPA strategies for DGDA & GMP compliance The pharmaceutical landscape in Bangladesh has evolved from a local manufacturing hub to a sophisticated global exporter. Read More …
10 Must-Follow Change Control Rules in Pharmaceutical Manufacturing
1. No Change Without Formal Approval In pharmaceutical manufacturing, no change—whether related to process, material, equipment, or documentation—should be implemented without prior approval through a formal Change Control system. Regulatory authorities like Directorate General of Drug Administration and US Food Read More …
Avoid CAPA Failure: Critical Writing Considerations in Pharmaceutical Industry
CAPA (Corrective and Preventive Action) is not just a documentation exercise—it is a regulatory expectation under Pharmaceutical Quality System (PQS) as per World Health Organization, US Food and Drug Administration, and International Council for Harmonisation. 🧩 1. Define the Problem Read More …
10 Golden Rules of Good Manufacturing Practice (GMP) Every Pharma Professional Must Know
🔑 1. Follow Written Procedures (SOPs) 📖 Explanation Every activity must be performed according to an approved SOP. SOPs ensure consistency, reproducibility, and compliance. 🧪 Real Example Case: Granulation process in solid dosage section 👉 Audit Finding: Process deviation👉 Impact: Read More …
Dissolution, Disintegration, Hardness & Friability Testers in Pharmaceutical QC
In pharmaceutical quality control (QC), solid oral dosage forms such as tablets and capsules must consistently meet predefined performance and mechanical integrity standards. Four essential instruments—dissolution tester, disintegration tester, hardness tester, and friability tester—play a critical role in ensuring compliance Read More …